Skip to main navigation Skip to search Skip to main content

Differential transplantability of tumor-associated stromal cells

Dan G. Duda, Dai Fukumura, Lance L. Munn, Michael F. Booth, Edward B. Brown, Peigen Huang, Brian Seed, Rakesh K. Jain

Research output: Contribution to journalArticlepeer-review

Abstract

At the time of transplantation, tumor fragments contain "passenger" cells: endothelial cells and other stromal cells from the original host. Here, we investigated the fate of genetically labeled endothelial and nonendothelial stromal cells after transplantation in syngeneic mice. We report that angiogenic stroma associated with tumor or adipose tissue persists when transplanted, remains functional, and governs the initial neovascularization of grafted tissue fragments for more than 4 weeks after implantation. Surprisingly, the passenger endothelial cells survive longer than other stromal cells, which are replaced by host-activated fibroblasts after 3 weeks. The transplantability of tumor stroma suggests that the angiogenic potential of a tumor xenograft, which determines its viability, depends on the presence of passenger endothelial cells and other stromal cells within the xenograft. These studies of tumor tissue transplantation provide a platform for exploring the role of epithelial-stromal interactions in studies of tumor heterogeneity and drug resistance.

Original languageEnglish (US)
Pages (from-to)5920-5924
Number of pages5
JournalCancer research
Volume64
Issue number17
DOIs
StatePublished - Sep 1 2004

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Differential transplantability of tumor-associated stromal cells'. Together they form a unique fingerprint.

Cite this